Compliance with Market Abuse Regulation

Summary by AI ^BETAClose X

Schroder UK Mid Cap Fund PLC has confirmed compliance with the Market Abuse Regulation, stating that all inside information will be notified via a regulatory information service before any dealings in its own securities occur. The mandatory closed period, which prohibits such dealings, is expected to end no sooner than Monday, June 29, 2026, coinciding with the anticipated announcement of the company's half-year results for the period ending March 31, 2026.

Disclaimer*

Schroder UK Mid Cap Fund PLC

29 May 2026

SCHRODER UK MID CAP FUND PLC

(the "Company")

Compliance with the Market Abuse Regulation ("MAR")

The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of its half year results for the period ended 31 March 2026 has previously been, and will continue to be, notified via a regulatory information service ("RIS"). Therefore, the Company is not prohibited from dealing in its own securities.

The mandatory closed period under MAR will last until the half year results in respect of the period ended 31 March 2026 are published and is anticipated to end no sooner than Monday, 29 June 2026.

If, in the period leading up to the announcement of the half year results, the Directors of the Company come into the possession of any inside information, this will be notified to an RIS before any such transactions are undertaken.

Enquiries:

Schroder Investment Management Limited

Phoebe Merrell

Tel: 020 7658 6000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END